COVID-19 Tied to Higher Mortality After Cardiac Arrest
MONDAY, Feb. 8, 2021 -- Among patients who suffer a cardiac arrest either in or out of hospital, those who are infected with COVID-19 are more likely to die than those who are not infected with COVID-19, according to a study published online Feb. 5 in the European Heart Journal.
Pedram Sultanian, from University of Gothenburg in Sweden, and colleagues used data from the Swedish Registry for Cardiopulmonary Resuscitation (Jan. 1 to July 20, 2020) to identify 1,946 cases of out-of-hospital cardiac arrest (OHCA) and 1,080 cases of in-hospital cardiac arrest (IHCA). Characteristics and outcomes of IHCA and OHCA were compared for the pandemic and prepandemic periods.
The researchers found that during the pandemic, 10.0 percent of OHCAs and 16.1 percent of IHCAs had ongoing COVID-19. The odds ratio (OR) for 30-day mortality in OHCA cases was 3.40 in COVID-19-positive patients, with a corresponding hazard ratio (HR) of 1.45, compared with COVID-19-negative patients. The adjusted 30-day survival rate was lower among patients with COVID-19 than patients without COVID-19 (4.7 versus 9.8 percent); 30-day survival was 7.6 percent in the prepandemic period. Among cases of IHCA, the odds for 30-day mortality were higher for COVID-19-positive status versus COVID-19-negative status (OR, 2.27), with a corresponding HR of 1.48. Following IHCA, adjusted 30-day survival was 23.1 percent in patients with COVID-19 compared with 39.5 percent in patients without COVID-19 and 36.4 percent in the prepandemic period.
"Our study clearly shows that cardiac arrest and COVID-19 is a very lethal combination," Sultanian said in a statement. "Patients with the coronavirus should be monitored intensively and measures taken to prevent cardiac arrest, for instance with the use of continuous heart monitors for patients at high risk."
© 2021 HealthDay. All rights reserved.
Posted: February 2021
Further Support and Information on COVID-19
Read this next
TUESDAY, March 2, 2021 -- Individuals with previous severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection generate strong responses to one dose of the BNT162b2...
TUESDAY, March 2, 2021 -- Treatment with interleukin-6 receptor antagonists tocilizumab and sarilumab improves outcomes among critically ill patients with COVID-19 receiving organ...
MONDAY, March 1, 2021 -- Walmart said it will expand its COVID-19 vaccination program to more than 1,400 pharmacies in 35 states. The retailer will also partner with local...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.